Blog
RSS FeedPosted by Michael Wonder on 20 Oct 2018
Is the EUnetHTA HTA core model fit for purpose? Evaluation from an industry perspective
18 October 2018 - The HTA Core Model was developed to improve the transferability of health technology assessment between settings. ...
Posted by Michael Wonder on 16 Oct 2018
Drug companies need to make costs more reasonable
16 October 2018 - Hundreds of women and their families marched on Parliament today to urge the funding of two ...
Posted by Michael Wonder on 15 Oct 2018
Drug industry will use ads to point consumers to price information
15 October 2018 - Stephen J. Ubl, president of the Pharmaceutical Research and Manufacturers of America, said prices in ads would ...
Posted by Michael Wonder on 11 Oct 2018
ABPI tells MPs Brexit deal on medicines regulation ‘urgently needed’
11 October 2018 - Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines ...
Posted by Michael Wonder on 01 Oct 2018
Abolishing drug rebates may push consumer drug costs higher
26 September 2018 - The Trump Administration has repeatedly said that controlling high drug prices is a top priority, and earlier ...
Posted by Michael Wonder on 26 Sep 2018
Big pharma boosts drug prices as supplies run low, study reveals
26 September 2018 - Federal lawmakers have been griping about drug pricing for years, led most recently by President Donald ...
Posted by Michael Wonder on 25 Sep 2018
Cost of clinical trials for new drug FDA approval are fraction of total tab
24 September 2018 - Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, ...
Posted by Michael Wonder on 20 Sep 2018
Health insurer takes pharma giant to court for ‘evergreening’
20 September 2018 - Health insurance group Menzis is taking legal action against Astra Zeneca, accusing the pharmaceuticals firm of ...
Posted by Michael Wonder on 20 Sep 2018
Non-profit takes on drug makers' lobbying on Medicare drug discount
19 September 2018 - A group seeking lower drug prices is launching new attacks on the pharmaceutical industry to stop ...
Posted by Michael Wonder on 20 Sep 2018
ACCC approves local merger of pharma firms Arrow and Apotex
20 September 2018 - Half of all generic prescriptions could come from one supplier after the competition watchdog approved a ...
Posted by Michael Wonder on 19 Sep 2018
My Health Record: big pharma can apply to access data
18 September 2018 - ‘Each application would be assessed on its own merits,’ senators told. ...
Posted by Michael Wonder on 19 Sep 2018
Huge price hikes by drug companies are immoral
19 September 2018 - Several pharmaceutical companies have been jacking up the prices of their drugs in unethical ways. ...
Posted by Michael Wonder on 18 Sep 2018
Harvard Professor's attack on pharma's clinical trials is absurd
18 September 2018 - Dr. Marcia Angell, a senior lecturer at Harvard Medical School and the first woman to serve as ...
Posted by Michael Wonder on 17 Sep 2018
Pharma companies avoid estimated $215m a year in local tax: Oxfam
18 September 2018 - Pharmaceutical companies behind some of Australia’s best-known brands avoided an estimated $215 million a year in ...
Posted by Michael Wonder on 17 Sep 2018
Antimicrobial resistance: FDA discusses reimbursement reforms
17 September 2018 - Reimbursement reforms for antimicrobial treatments could include “a mix of milestone payments and subscription fees for ...